Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

被引：0

作者：

Massimo Di Maio

Ethan Basch

Jane Bryce

Francesco Perrone

机构：

[1] San Luigi Gonzaga Hospital,Massimo Di Maio is at the Department of Oncology

[2] University of Turin,undefined

[3] Regione Gonzole 10,undefined

[4] 10043 Orbassano (TO),undefined

[5] Italy.,undefined

[6] Ethan Basch is at the Cancer Outcomes Research Program,undefined

[7] Lineberger Comprehensive Cancer Center,undefined

[8] University of North Carolina,undefined

[9] Chapel Hill,undefined

[10] North Carolina 27599,undefined

[11] USA.,undefined

[12] Jane Bryce and Francesco Perrone are at the Clinical Trials Unit,undefined

[13] Istituto Nazionale per lo Studio e la Cura dei Tumori - Fondazione G. Pascale IRCCS,undefined

[14] via Mariano Semmola,undefined

[15] 80131 Napoli,undefined

[16] Italy.,undefined

来源：

Nature Reviews Clinical Oncology | 2016年 / 13卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Reporting of toxic adverse effects of anticancer treatments by clinicians generally results in the underreporting of these toxicities. Patient-reported outcomes, which fully reflect the experiences of patients receiving treatment, offer an alternative to reporting of toxicities by clinicians. In this Perspective, the authors describe the barriers and challenges to routine integration of patient-reported outcomes into clinical trials, and describe the PRO–CTCAE, which is designed to help circumvent some of these challenges.

引用

页码：319 / 325

页数：6

共 50 条

[1] Patient-reported outcomes in the evaluation of toxicity of anticancer treatments
Di Maio, Massimo
Basch, Ethan
Bryce, Jane
Perrone, Francesco
[J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (05) : 319 - 325
[2] Patient-reported outcomes in evaluation of chemotherapy toxicity in women with gynecologic malignancies
Webster, E. M.
Ware, H.
Jones, B. A.
Vattakalam, R. M.
Wright, J. D.
Tergas, A. I.
Burke, W. M.
Hou, J. Y.
[J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 216 - 216
[3] Electronic Toxicity Monitoring and Patient-Reported Outcomes
Basch, Ethan M.
Reeve, Bryce B.
Mitchell, Sandra A.
Clauser, Stephen B.
Minasian, Lori
Sit, Laura
Chilukuri, Ram
Baumgartner, Paul
Rogak, Lauren
Blauel, Emily
Abernethy, Amy P.
Bruner, Deborah
[J]. CANCER JOURNAL, 2011, 17 (04): : 231 - 234
[4] Patient-reported outcomes supporting anticancer product approvals
Rock, Edwin P.
Kennedy, Dianne L.
Furness, Melissa H.
Pierce, William F.
Pazdur, Richard
Burke, Laurie B.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (32) : 5094 - 5099
[5] Patient-reported outcomes in drug safety evaluation
Basch, E.
[J]. ANNALS OF ONCOLOGY, 2009, 20 (12) : 1905 - 1906
[6] Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity
Peach, M. Sean
Trifiletti, Daniel M.
Vachani, Carolyn
Arnold-Korzeniowski, Karen
Bach, Christina
Hampshire, Margaret
Metz, James M.
Hill-Kayser, Christine E.
[J]. PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 245 - 252
[7] PATIENT-REPORTED OUTCOMES: IS THIS THE FUTURE FOR THE DEVELOPMENT OF TREATMENTS IN MUSCULOSKELETAL DISEASES?
Boers, M.
[J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S38 - S38
[8] Patient-reported outcomes
Garratt, Andrew
[J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (07) : 668 - 668
[9] Patient-reported outcomes Recording and evaluating patient-reported endpoints
Hilser, Thomas
Darr, Christopher
Gruenwald, Viktor
[J]. ONKOLOGIE, 2022, 28 (10): : 940 - 946
[10] How prominent are patient-reported outcomes in clinical trials of dermatological treatments?
Townshend, A. P.
Chen, C-M.
Williams, H. C.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (05) : 1152 - 1159

← 1 2 3 4 5 →